Back to discover
Drug

Kaempferol

In clinical development
Emerging researchEarly-to-mid development
RxNorm2743006ChEMBLCHEMBL150UNII731P2LE49E
2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Kaempferol
RxNorm CUI
2743006
ChEMBL ID
CHEMBL150
UNII
731P2LE49E

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
LATEST COMPLETION 2024
1
Completed
PHASE DISTRIBUTIONn = 1
Phase 11

Recent completions

Trials that read out recently, adding to the completed evidence base.

Randomized Controlled Trial Studying the Ameliorating Effects of Kaempferol Emulgel on Female Arousal Disorder and Sexual Dysfunction

CompletedPH IDeraya Universityn=302024

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20192021
Journals, researchers & institutions
Top journals
  • Biomolecules1
  • Nutrients1
Leading researchers
  • Chen J1
  • Dabeek WM1
  • Marra MV1
  • Wang H1
  • Xu X1
  • Yuan Y1
  • Zhai Y1
Leading institutions
free-text, unnormalised
  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital1
  • West Virginia University1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Quercetin

Studied across the same disease area as Kaempferol in the shared literature.

1 shared disease1 shared paper
Oxygen

Frequently co-studied with Kaempferol in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials